Updates are available Correction dated 2025-11-12
Click to view Correction: https://doi.org/10.1038/s41586-025-09879-y
-
Authors
Shmatko, Artem https://orcid.org/0000-0002-2184-0856
Jung, Alexander Wolfgang https://orcid.org/0000-0001-8416-6849
Gaurav, Kumar
Brunak, Søren https://orcid.org/0000-0003-0316-5866
Mortensen, Laust Hvas
Birney, Ewan https://orcid.org/0000-0001-8314-8497
Fitzgerald, Tom https://orcid.org/0000-0002-2370-8496
Gerstung, Moritz https://orcid.org/0000-0001-6709-963X
- License Information
-
More Information
Article History
Received: 18 May 2024
Accepted: 13 August 2025
First Online: 17 September 2025
Change Date: 12 November 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-025-09879-y
Competing interests
: A patent has been filed for the use of generative transformer architectures to model competing risk and timings of diseases (application number: PCT/EP2025/065771; applicants: DKFZ, EMBL), with M.G., A.S., T.F., E.B., K.G. and A.W.J. listed as inventors. S.B. has ownership interests in Hoba Therapeutics Aps, Novo Nordisk, Lundbeck and Eli Lilly. E.B. is a consultant and shareholder of Oxford Nanopore. The other authors declare no competing interests.
